Slideshow

Depression Research Update: July 2018

Author(s):

Mark L. Fuerst

Highlights of 3 new studies investigate how to choose the best therapy for depression as well as the negative influences of polypharmacy and social media.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe Now!
Related Videos
McIntyre
John Krystal
peshkova Adobestock
brain connections
schism
electric brain
Related Content
Exploring NMDA Antagonists for MDD
July 12th 2025

Exploring NMDA Antagonists for MDD

Heidi Anne Duerr, MPH
Blue Light Blockers: A Behavior Therapy for Mania
October 7th 2021

Blue Light Blockers: A Behavior Therapy for Mania

Chris Aiken, MD Kellie Newsome, PMH-NP
GLP 1
July 7th 2025

Transformation 2.0: The GLP-1 RAs as Psychiatric Medications?

Roger S. McIntyre, MD, FRCPC
Blue Light, Depression, and Bipolar Disorder
August 4th 2021

Blue Light, Depression, and Bipolar Disorder

Chris Aiken, MD Kellie Newsome, PMH-NP
psychedelic
July 1st 2025

Positive Results From the Phase 2b Study of BPL-003 in Patients With Treatment-Resistant Depression

Leah Kuntz
ytemha34/AdobeStock
June 30th 2025

Mount Sinai Researchers Uncover a Promising New Way to Modulate Brain Cell Activity to Potentially Treat Major Depressive Disorder in Adults

Elizabeth Dowling
© 2025 MJH Life Sciences

All rights reserved.